Bharat Rasayan Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
BHARATRAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.3 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bharat Rasayan Limited reported standalone revenue of ₹1,24,184 Lacs for FY2026, up 5.9% from ₹1,17,300 Lacs in FY2025. Profit after tax grew 14.2% to ₹14,293 Lacs from ₹12,510 Lacs. Operating margin expanded significantly from 14.97% to 17.51%. The Board recommended a final dividend of ₹0.50 per share (10%) subject to shareholder approval. During the year, the company completed a share split (₹10 to ₹5 face value) and 1:1 bonus issue, increasing paid-up capital from ₹4.15 Cr to ₹8.31 Cr. Key Board changes include the resignation of Whole-Time Director Shri Mahabir Prasad Gupta (health reasons) and appointment of his son Shri Vikas Gupta as Additional Director from July 1, 2026. An independent director's tenure also concluded. The company's CARE ratings remain AA- (Long Term) and A1+ (Short Term). Insurance claim for Dahej plant damage is underway. Auditors expressed an unmodified opinion.
Strong profitability improvement with margin expansion is positive for investors. The related-party appointment of a promoter family member warrants monitoring. The share split and bonus issue adjusts per-share metrics for comparability.